X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Torrent Pharma Quarterly Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Torrent Pharma Quarterly Results   (TORR)

Here are the latest quarterly results of Torrent Pharma. For more details, see the Torrent Pharma financial fact sheet and Torrent Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Torrent Pharma Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-15
*
3
Jun-15
*
3
Sep-15
*
3
Dec-15
*
3
Mar-16
*
3
Jun-16
*
3
Sep-16
*
3
Dec-16
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m11,54019,47016,91015,39014,99015,45014,29014,430 
Other income Rs m1,000670740510240260430500 
Turnover Rs m12,54020,14017,65015,90015,23015,71014,72014,930 
Expenses Rs m9,92010,3809,7709,26010,15011,08010,99011,270 
Gross profit Rs m1,6209,0907,1406,1304,8404,3703,3003,160 
Depreciation Rs m600590610610650680690730 
Interest Rs m470580480420380490510480 
Profit before tax Rs m1,5508,5906,7905,6104,0503,4602,5302,450 
Tax Rs m2504,1001,640780480540460160 
Profit after tax Rs m1,3004,4905,1504,8303,5702,9202,0702,290 
Gross profit margin %14.046.742.239.832.328.323.121.9 
Effective tax rate %16.147.724.213.911.915.618.26.5 
Net profit margin %11.323.130.531.423.818.914.515.9 
Diluted EPS Rs 7.7 26.5 30.4 28.5 21.1 17.3 12.2 13.5  
Diluted EPS (TTM) Rs 44.4 55.8 74.5 93.2 106.6 97.3 79.1 64.1  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   NOVARTIS  J.B.CHEMICALS  ELDER PHARMA  PLETHICO PHARMA  IPCA LABS  

Compare TORRENT PHARMA With:   NOVARTIS  J.B.CHEMICALS  ELDER PHARMA  PLETHICO PHARMA  IPCA LABS  

Compare TORRENT PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Hits Record High; Capital Goods & Bank Stocks Rally(Closing)

Indian share markets continued to witness strong buying momentum in the afternoon trade tracking a firm trend in international markets.

Views on news

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Glenmark: Zetia Generics Boost Growth (Quarterly Results Update - Detailed)

Feb 15, 2017

Glenmark has announced its 3QFY16 results. The company has reported 41% YoY growth in net sales and 143.2% YoY increase in net profits. Here is our analysis of the results.

More Views on News

Most Popular

New IIP Shows Demonetisation Slowed Down Indian Manufacturing Growth Big Time(Vivek Kaul's Diary)

May 16, 2017

The manufacturing growth between December 2016 and March 2017 fell to 1.6 per cent as against 6.9 per cent between April and October 2016.

How to Generate a 17.28% Profit in Days(Daily Profit Hunter)

May 12, 2017

Apurva shows how a simple but effective pattern has helped him generate returns like 9.09%, 11.41%, and 17.89%.

Read This Before Throwing Out the 'Bad' IT Stocks(The 5 Minute Wrapup)

May 12, 2017

A template that will help you identify the 'emphatic sells'.

Just Like Before, the Market is about to Crash(Outside View)

May 17, 2017

Markets are at record highs. Fear is at record lows. How does this end? When does this end?

Are You Saving & Investing Enough To Become A Crorepati?(Outside View)

May 13, 2017

Savings alone can't help you become rich. Investing in wealth generating investment avenues strategically is the key.

More

TORRENT PHARMA SHARE PRICE


May 25, 2017 (Close)

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 5-YR ANALYSIS

COMPARE TORRENT PHARMA WITH

MARKET STATS